CRISPR Therapeutics Stock (NASDAQ: CRSP) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 1.196K / 1.750M |
Day Range | - - - |
52 Wk Range | 37.550 - 91.100 |
Market Cap | $4.914B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 35 |
Short Interest | 19.72% |
Days to Cover | 12.19 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of CRISPR Therapeutics (NASDAQ: CRSP) through any online brokerage.
There are no as such competitors for CRISPR Therapeutics.
The latest price target for CRISPR Therapeutics (NASDAQ: CRSP) was reported by Citigroup on Thursday, April 18, 2024. The analyst firm set a price target for 89.00 expecting CRSP to rise to within 12 months (a possible 53.74% upside). 47 analyst firms have reported ratings in the last year.
The stock price for CRISPR Therapeutics (NASDAQ: CRSP) is $57.89 last updated Today at April 24, 2024 at 5:05 AM EDT.
There are no upcoming dividends for CRISPR Therapeutics.
CRISPR Therapeutics’s Q1 earnings are confirmed for Monday, May 6, 2024.
There is no upcoming split for CRISPR Therapeutics.
CRISPR Therapeutics is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.